Zobrazeno 1 - 10
of 2 480
pro vyhledávání: '"Narkevich AN"'
Autor:
article Editorial
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 4, Pp 10-11 (2021)
On October 29, 2021, the rector of the SPCPU Igor Anatolyevich Narkevich celebrated his 55th anniversary.
Externí odkaz:
https://doaj.org/article/1b2c60d0326d4007bd9adae4ebb11178
Publikováno v:
Pharmacy Formulas.
The article is dedicated to the fifty-fifth birthday of a remarkable person, Professor, Rector of the Saint Petersburg Chemical and Pharmaceutical University Igor Anatolyevich Narkevich. Little-known facts about his personal life and career have been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26b367a4184db167a9a74cb870e5428b
https://doi.org/10.17816/phf110916
https://doi.org/10.17816/phf110916
Publikováno v:
Радиационная гигиена, Vol 10, Iss 4, Pp 79-80 (2018)
Externí odkaz:
https://doaj.org/article/d0039d12c11c4c61984fdbd1901f813c
Autor:
D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich
Publikováno v:
Фармакоэкономика, Vol 17, Iss 1, Pp 106-117 (2024)
The article aims to examine technological, organizational and regulatory aspects of drug quality and safety assurance system, as well as peculiarities in civil circulation of extemporaneous drugs in Latvian pharmaceutical market to improve approaches
Externí odkaz:
https://doaj.org/article/dda0c9863bdc4aeabd6d69c4810b90ec
Autor:
P. K. Karnakova, T. N. Komarov, O. A. Archakova, D. Yu. Ivkin, E. S. Vetrova, I. I. Terninko, I. E. Shohin, I. A. Narkevich
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 13, Iss 1, Pp 257-271 (2024)
Introduction. Etmaben is a promising drug for the treatment of cardiovascular diseases, widely studied in preclinical studies. In order to conduct phase I clinical trials, it is necessary to develop a bioanalytical method for the quantitative determi
Externí odkaz:
https://doaj.org/article/e2625f9dbbf5438f998e1e0314663ac4
Development of approaches to the evaluation of pharmacotherapy effectiveness for chronic hepatitis C
Autor:
I. A. Narkevich, E. A. Tsitlionok
Publikováno v:
Фармакоэкономика, Vol 16, Iss 4, Pp 607-618 (2024)
Objective: to analyse the consumption pattern of antiviral therapy (AVT) for chronic hepatitis C on the example of an infectious hospital.Material and methods. The study was based on data from 380 discharge summaries of an infectious diseases hospita
Externí odkaz:
https://doaj.org/article/25fb82c39762481ba857c81a7cc13f83
Autor:
S. E. Erdni-Garyaev, D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, Z. M. Golant, V. S. Fisenko, I. A. Narkevich
Publikováno v:
Регуляторные исследования и экспертиза лекарственных средств, Vol 14, Iss 1, Pp 91-109 (2024)
SCIENTIFIC RELEVANCE. There is a need to move towards an appropriate system of quality assurance in pharmacy compounding. At the same time, the development of a Russian regulatory system for pharmacy compounding requires a broad understanding of inte
Externí odkaz:
https://doaj.org/article/e767d6c440824a6189a585c19e8dd8b5
Autor:
L. V. Narkevich, P. V. Tereliansky
Publikováno v:
E-Management, Vol 6, Iss 4, Pp 22-40 (2024)
The article presents the developed information and analytical platform for working capital management according to the methodology of a systematic approach, considering the specifics of textile production and modern requirements of preventive crisis
Externí odkaz:
https://doaj.org/article/01d7778b76d9424e9e787dc8de601335
Autor:
K. M. Tserkovnaya, E. V. Flisyuk, Ju. M. Kotsur, I. A. Narkevich, I. E. Smekhova, D. Yu. Ivkin, N. V. Filimonova
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 4, Pp 155-164 (2023)
Introduction. A personalized choice of antihypertensive combinations and doses is one of the promising trend in the field of combination therapy of arterial hypertension (AH). A polypill as a solid gelatin capsule with combination of mini-tablets can
Externí odkaz:
https://doaj.org/article/5b8d74a8de5840e6ba425fbc34323f6a
Autor:
Yu. M. Kotsur, K. M. Tserkovnaya, E. V. Flisyuk, I. A. Titovich, K. O. Sidorov, I. A. Narkevich
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 4, Pp 96-100 (2023)
Introduction. A comprehensive study of the active pharmaceutical ingredient (API) molecule is one of the defining criteria for pharmaceutical development according to the Quality by Design (QbD) concept and the ICH Q8 framework. The spatial arrangeme
Externí odkaz:
https://doaj.org/article/82d73a53a104449fa106c0033b3b3026